JPXN:NYE-iShares JPX-Nikkei 400 ETF (USD)

ETF | Japan Stock |

Last Closing

USD 76.71

Change

+0.16 (+0.21)%

Market Cap

N/A

Volume

2.40K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

+0.01 (+0.03%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

+0.09 (+0.13%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

-0.05 (-0.16%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

+0.27 (+0.33%)

N/A
DXJ WisdomTree Japan Hedged Equity..

+0.25 (+0.24%)

N/A
EWJ iShares MSCI Japan ETF

+0.10 (+0.14%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

-0.01 (-0.03%)

N/A
HEWJ iShares Currency Hedged MSCI J..

+0.01 (+0.02%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

+0.05 (+0.06%)

N/A

ETFs Containing JPXN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.82% 60% D- 65% D
Dividend Return 0.87% 40% F 14% F
Total Return 13.69% 60% D- 60% D-
Trailing 12 Months  
Capital Gain 22.79% 80% B- 58% F
Dividend Return 3.01% 80% B- 40% F
Total Return 25.81% 70% C- 56% F
Trailing 5 Years  
Capital Gain 27.34% 50% F 59% D-
Dividend Return 6.84% 30% F 20% F
Total Return 34.18% 40% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 4.99% N/A N/A 55% F
Dividend Return 6.27% N/A N/A 51% F
Total Return 1.29% N/A N/A 30% F
Risk Return Profile  
Volatility (Standard Deviation) 18.20% N/A N/A 56% F
Risk Adjusted Return 34.48% N/A N/A 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike